The plasma membrane dopamine transporter (DAT) has an essential role in terminating dopaminergic neurotransmission by reuptake of dopamine into the presynaptic neurons. Therefore, the amount of DAT at the cell surface is a critical determinant of DAT function. In this study, we examined the role of the carboxyl terminus of DAT in trafficking of the transporter through the biosynthetic pathway to the plasma membrane. Live cell fluorescence microscopy and cell surface biotinylation were used to study the effects of systematic deletions and alanine substitutions in the carboxyl terminus on DAT localization. It was found that alanine substitutions of Lys-590 and Asp-600 significantly delayed the delivery of DAT to the plasma membrane because of retention of DAT in the endoplasmic reticulum (ER). Most surprising, mutation of Gly-585 to alanine completely blocked the exit of DAT from the ER and surface expression of the transporter. The effect of these three mutations on ER export of DAT was demonstrated in porcine aortic endothelial cells and the immortalized neuronal cell line 1RB 3 AN 27 . In primary cultures of rat embryonic midbrain neurons, DAT G585A, K590A, and D600A mutants were restricted to the cell soma and did not traffic to the dendrites or axonal processes. These data are consistent with the model whereby the local conformation and/or intramolecular interactions of the sequences of the DAT carboxyl terminus proximal to the last transmembrane domain are essential for the ER export of the transporter.Dopaminergic neurotransmission plays a critical role in modulation of a variety of central nervous system functions, including locomotor activity, cognition, and reward (1). Dopamine signaling is initiated by release of dopamine from the presynaptic neuron cell, and its duration and intensity are regulated primarily by the reuptake of dopamine back into the dopaminergic neurons by the plasma membrane dopamine transporter (DAT).1 DAT belongs to the family of Na ϩ /Cl Ϫ -dependent plasma membrane neurotransmitter transporters, which includes the norepinephrine, serotonin (SERT), glycine, and ␥-aminobutyric acid transporters (2). DAT is a 620-amino acid polypeptide embedded in the lipid bilayer by 12 hydrophobic segments. Both amino and carboxyl termini are predicted to be intracellular. The second extracellular loop contains at least three consensus N-glycosylation sites (3-5).In the mammalian brain, DAT is found in all parts of dopamine neurons, including in cell bodies and dendrites in substantia nigra and ventral tegmental area and in axonal termini in striatum and cerebral cortex. The maximal surface expression of DAT is detected in synapses located along the axonal processes in striatum and in distal regions of dendrites in the ventral tegmental area (6, 7). This specific targeting and the normal activity of DAT in neurons require efficient export of newly synthesized transporters from the ER, sorting to transport carriers in the Golgi complex, and delivery and retention of the transporters at the presynapt...